Cargando…
The Case for Clinical Trials with Novel GABAergic Drugs in Diabetes Mellitus and Obesity
Obesity and diabetes mellitus have become the surprising menaces of relative economic well-being worldwide. Gamma amino butyric acid (GABA) has a prominent role in the control of blood glucose, energy homeostasis as well as food intake at several levels of regulation. The effects of GABA in the body...
Autor principal: | Antoni, Ferenc A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876029/ https://www.ncbi.nlm.nih.gov/pubmed/35207609 http://dx.doi.org/10.3390/life12020322 |
Ejemplares similares
-
An international comparison of noncommunicable disease reporting: the case of diabetes mellitus
por: Reitzle, Lukas, et al.
Publicado: (2019) -
Critical Parameters for the Development of Novel Therapies for Severe and Resistant Infections—A Case Study on CAL02, a Non-Traditional Broad-Spectrum Anti-Virulence Drug
por: Azeredo da Silveira, Samareh, et al.
Publicado: (2020) -
Toward Practical Integration of Omic and Imaging Data in Co-Clinical Trials
por: Alkim, Emel, et al.
Publicado: (2023) -
Concussion Office Based Rehabilitation Assessment: A Novel Clinical Tool for Concussion Assessment and Management
por: Katz, Matthew, et al.
Publicado: (2020) -
From Parasitized to Healthy-Looking Ants (Hymenoptera: Formicidae): Morphological Reconstruction Using Algorithmic Processing
por: Csősz, Sándor, et al.
Publicado: (2022)